Provided by Tiger Fintech (Singapore) Pte. Ltd.

Larimar Therapeutics, Inc.

3.57
+0.04001.13%
Pre-market: 3.57-0.0002-0.01%08:00 EDT
Volume:4.40M
Turnover:15.56M
Market Cap:228.58M
PE:-2.39
High:3.89
Open:3.67
Low:3.27
Close:3.53
Loading ...

Larimar Therapeutics Inc. Files Prospectus for Public Offering, Raising Approximately $64.4 Million

Reuters
·
2 hours ago

BUZZ-U.S. STOCKS ON THE MOVE-Electronic Arts, AEP, Peloton Interactive

Reuters
·
20 hours ago

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Hershey, Wingstop

Reuters
·
Yesterday

BUZZ-U.S. STOCKS ON THE MOVE-Visa, Kraft Heinz, Humana

Reuters
·
Yesterday

BRIEF-Larimar Therapeutics Prices Public Offering at $3.20 Per Share

Reuters
·
Yesterday

Larimar Therapeutics Inc - Prices Public Offering at $3.20 per Share

THOMSON REUTERS
·
Yesterday

Larimar Therapeutics Announces Pricing of Underwritten Public Offering

THOMSON REUTERS
·
Yesterday

Larimar Therapeutics Inc. Reports Preliminary Cash Holdings of $138.5 Million for Q2 2025

Reuters
·
Yesterday

BUZZ-Larimar Therapeutics falls on stock offering launch

Reuters
·
Yesterday

Larimar Therapeutics - Leerink Partners and Guggenheim Securities Are Joint Bookrunning Managers for Offering

THOMSON REUTERS
·
Yesterday

Larimar Therapeutics Inc - Grants Underwriters Option to Buy 15% More Securities

THOMSON REUTERS
·
Yesterday

Larimar Therapeutics’ nomlabofusp shows therapeutic potential in FA

TIPRANKS
·
08 Jul

Larimar Therapeutics (LRMR) Gets a Buy from Guggenheim

TIPRANKS
·
26 Jun

JonesTrading Reaffirms Their Buy Rating on Larimar Therapeutics (LRMR)

TIPRANKS
·
24 Jun

Wedbush Adjusts Larimar Therapeutics Price Target to $15 From $17, Maintains Outperform Rating

MT Newswires Live
·
23 Jun

Larimar Therapeutics Announces FDA Safety Database Recommendations and Refines Timeline for BLA Submission for Friedreich's Ataxia Program

Reuters
·
23 Jun

BRIEF-Larimar Therapeutics announces regulatory update call on Nomlabofusp Program

Reuters
·
21 Jun

Larimar Therapeutics Inc. Conducted Annual Stockholders Meeting Virtually

Reuters
·
14 May

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), PTC Therapeutics (PTCT) and Larimar Therapeutics (LRMR)

TIPRANKS
·
06 May

Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Humana (HUM) and Larimar Therapeutics (LRMR)

TIPRANKS
·
01 May